Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alimera Sciences Company Profile (NASDAQ:ALIM)

Consensus Ratings for Alimera Sciences (NASDAQ:ALIM) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $9.38 (110.20% upside)

Analysts' Ratings History for Alimera Sciences (NASDAQ:ALIM)
Show:
DateFirmActionRatingPrice TargetActions
5/8/2015Cantor FitzgeraldSet Price TargetBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Cantor FitzgeraldReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015ZacksDowngradeNeutral$5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Cantor FitzgeraldInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Summer StreetInitiated CoverageBuy -> Buy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2014Northland SecuritiesBoost Price TargetOutperform$7.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Northland SecuritiesBoost Price Target$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2013Cowen and CompanyUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2013Northland SecuritiesInitiated CoverageOutperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2013Northland SecuritiesInitiated CoverageOutperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2013 forward)